News

News Subscription

Jul 19. 2018
Basilea reports receipt of milestone payment based on first Cresemba® approval in Latin America
Read more
Download
Jun 26. 2018
Basilea starts clinical phase 2a expansion with BAL101553 in ovarian cancer and glioblastoma
Read more
Download
Jun 05. 2018
Basilea reports presentation of phase 1 clinical data with anticancer drug candidate BAL101553 at ASCO meeting
Read more
Download
May 24. 2018
Basilea Pharmaceutica: Subscription to Basilea's Press Release Newsletter
Read more
May 15. 2018
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Saudi Arabia by Hikma Pharmaceuticals LLC
Read more
Download
Apr 27. 2018
Basilea announces appointment of Chief Technology Officer and appointment of Head of Global Quality Management
Read more
Download
Apr 20. 2018
Basilea reports presentations of isavuconazole and ceftobiprole data at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Read more
Download
Apr 19. 2018
Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting of Shareholders
Read more
Download
Apr 18. 2018
Basilea reports start of clinical phase 3 study in Japan by Asahi Kasei Pharma with antifungal isavuconazole
Read more
Download
Apr 17. 2018
Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Read more
Download